Michael J. Higgins - 30 Nov 2023 Form 3 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role: Director
Signature: /s/ Michael Higgins
Issuer symbol: CYCN
Transactions as of: 30 Nov 2023
Net transactions value: $0
Form type: 3
Filing time: 07 Dec 2023, 16:05:17 UTC
Previous filing: 07 Jun 2023
Next filing: 07 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CYCN	Common Stock						21,650	30 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Prior to becoming a Reporting Person, Mr. Higgins held 1,650 shares of common stock of Cyclerion Therapeutics, Inc. On November 30, 2023, the Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan, of which 2,500 of these shares vest immediately and the remaining 17,500 shares vest ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.

Content

Prior to becoming a Reporting Person, Mr. Higgins held 1,650 shares of common stock of Cyclerion Therapeutics, Inc. On November 30, 2023, the Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan, of which 2,500 of these shares vest immediately and the remaining 17,500 shares vest ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.